Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Has announcements × Doxorubicin × Clear all

Phase

Status

Sponsor Class

INDUSTRY 5 OTHER 1 NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, B-Cell 1 Burkitt Lymphoma 1

Interventions

toripalimab 1 sodium thiosulfate 1 naxitamab 1 Vincristine 1 Rituximab 1 Methotrexate 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Eflornithine 1 Drug Therapy 1 Doxorubicin 1 Daunorubicin 1 Cytarabine 1 Cyclophosphamide 1 Cisplatin 1 Abatacept 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01516580 2026-02-09

Intergroup Randomized Trial for Children or Adolescents With B-Cell Non Hodgkin Lymphoma or B-Acute Leukemia: Rituximab Evaluation in High Risk Patients

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Completed

482 enrolled 1 FDA

Burkitt Lymphoma, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡